Our Vision

We aspire to individualize cancer medicine

Imagine you could tailor-make a cancer therapy for each individual patient, based on the genetic features of the tumor and provide it in a reproducible, timely and cost-effective way. We aim to change the treatment paradigm for cancer patients worldwide.

We are a next generation immunotherapy powerhouse pioneering individualized immunotherapies

BioNTech was founded in 2008 on the understanding that every cancer patient’s tumor is unique and therefore each patient’s treatment should be individualized. To translate this idea into reality, we have combined ground-breaking research with cutting-edge technologies to develop pioneering therapeutics for cancer and beyond. As we prove the value of our approach in the clinic, we will continue to build the partnerships, manufacturing and team required to bring individualized treatments to patients worldwide. From our roots in Mainz, Germany, we are driven to become the leading global biotechnology company for individualized cancer medicine.